日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Re-appraising assays on permeabilized blood cancer cells testing venetoclax or other BH3 mimetic agents selectively targeting pro-survival BCL2 proteins.

重新评估在透化血癌细胞上测试维奈托克或其他 BH3 模拟剂的试验,这些药物选择性地靶向促生存 BCL2 蛋白

Gong Jia-Nan, Djajawi Tirta M, Moujalled Donia M, Pomilio Giovanna, Khong Tiffany, Zhang Li-Ping, Fedele Pasquale L, Low Michael S, Anderson Mary Ann, Riffkin Christopher D, White Christine A, Lan Ping, Lessene Guillaume, Herold Marco J, Strasser Andreas, Spencer Andrew, Grigoriadis George, Wei Andrew H, van Delft Mark F, Roberts Andrew W, Huang David C S

Retreatment with venetoclax and rituximab following disease progression while off therapy in patients with chronic lymphocytic leukemia

慢性淋巴细胞白血病患者停药后疾病进展,可使用维奈托克和利妥昔单抗进行再治疗

Brander, Danielle M; Roberts, Andrew W; Kipps, Thomas J; Ma, Shuo; Anderson, Mary Ann; Boyer, Michelle; Blombery, Piers; Popovic, Relja; Roser, Jordan; Liu, Zhuangzhuang; Chyla, Brenda; Seymour, John F

Resistance to targeted therapies in chronic lymphocytic leukemia: Current status and perspectives for clinical and diagnostic practice

慢性淋巴细胞白血病靶向治疗耐药性:现状及临床和诊断实践展望

Blombery, Piers; Chatzikonstantinou, Thomas; Gerousi, Marina; Rosenquist, Richard; Gaidano, Gianluca; Pospisilova, Sarka; Roberts, Andrew W; Birkinshaw, Richard W; Rossi, Davide; Scarfo, Lydia; Seymour, John F; Stilgenbauer, Stephan; Wiestner, Adrian; Woyach, Jennifer A; Brown, Jennifer R; Ghia, Paolo; Stamatopoulos, Kostas

Emergent BAX-mutated clonal hematopoiesis after venetoclax-based therapy for breast cancer

乳腺癌患者接受维奈托克治疗后出现BAX突变克隆性造血

Tiong, Ing S; Nguyen, Tamia; Chua, Chong C; Teh, Charis E; Muttiah, Christine; Ftouni, Sarah; Seymour, John F; Gray, Daniel; Roberts, Andrew W; Dawson, Sarah-Jane; Lindeman, Geoffrey J; Blombery, Piers

Enterocolitis associated with glofitamab-First report and clinicopathological findings in three cases

与 glofitamab 相关的肠炎——首例报告及三例临床病理学发现

McKeague, Sean; Robertson, Molly; van der Linde, Sam; Khoo, Christine; Segal, Jonathan; Harrop, Sean; Minson, Adrian; Roberts, Andrew W; Dickinson, Michael

Real-World Health Care Resource Utilization and Costs Associated With First-Line Dronedarone Versus First-Line Ablation in Adults With Atrial Fibrillation

真实世界中,一线使用决奈达隆与一线消融治疗成人房颤患者的医疗资源利用情况及相关成本

Greene, Stephen J; Schilsky, Samantha; Roberts, Andrew W; Kabadi, Shaum M; McKindley, David S; Preblick, Ron; Rashkin, Jason; Leeming, Reno C; Sajedian, Renee M; Russo, Andrea M

A case of enterovirus D68-associated acute flaccid myelitis in an immunocompromised adult, Australia

澳大利亚一例免疫功能低下成人肠道病毒D68相关急性弛缓性脊髓炎病例报告

Lizak, Nathaniel; Butel-Simoes, Grace; Steinig, Eike; Cruse, Belinda; Rodrigues, Edrich; Buising, Kirsty; Sasadeusz, Joe; Krysiak, Marcelina; Thorley, Bruce; Kaye, Matthew; Caly, Leon; Moselen, Jean; Savic, Ivana; Roberts, Andrew W; Bond, Katherine; Lim, Chuan Kok; Williamson, Deborah A; Ramachandran, Prashanth

Venetoclax dose escalation rapidly activates a BAFF/BCL-2 survival axis in chronic lymphocytic leukemia

维奈托克剂量递增可迅速激活慢性淋巴细胞白血病中的 BAFF/BCL-2 生存轴。

Luo, Meng-Xiao; Tan, Tania; Trussart, Marie; Poch, Annika; Nguyen, Thi Minh Hanh; Speed, Terence P; Hicks, Damien G; Bandala-Sanchez, Esther; Peng, Hongke; Chappaz, Stéphane; Slade, Charlotte; Utzschneider, Daniel T; Koldej, Rachel M; Ritchie, David; Strasser, Andreas; Thijssen, Rachel; Ritchie, Matthew E; Tam, Constantine S; Lindeman, Geoffrey J; Huang, David C S; Lew, Thomas E; Anderson, Mary Ann; Roberts, Andrew W; Teh, Charis E; Gray, Daniel H D

How comparable are patient outcomes in the "real-world" with populations studied in pivotal AML trials?

真实世界中患者的治疗结果与关键性 AML 试验中研究人群的治疗结果有多大可比性?

Tiong, Ing Soo; Wall, Meaghan; Bajel, Ashish; Kalro, Akash; Fleming, Shaun; Roberts, Andrew W; Thiagarajah, Nisha; Chua, Chong Chyn; Latimer, Maya; Yeung, David; Marlton, Paula; Johnston, Amanda; Enjeti, Anoop; Fong, Chun Yew; Cull, Gavin; Larsen, Stephen; Kennedy, Glen; Schwarer, Anthony; Kipp, David; Ramanathan, Sundra; Verner, Emma; Tiley, Campbell; Morris, Edward; Hahn, Uwe; Moore, John; Taper, John; Purtill, Duncan; Warburton, Pauline; Stevenson, William; Murphy, Nicholas; Tan, Peter; Beligaswatte, Ashanka; Mutsando, Howard; Hertzberg, Mark; Shortt, Jake; Szabo, Ferenc; Dunne, Karin; Wei, Andrew H

Six-year follow-up and subgroup analyses of a phase 2 trial of venetoclax for del(17p) chronic lymphocytic leukemia

一项针对del(17p)慢性淋巴细胞白血病的维奈托克II期临床试验的六年随访和亚组分析

Stilgenbauer, Stephan; Tausch, Eugen; Roberts, Andrew W; Davids, Matthew S; Eichhorst, Barbara; Hallek, Michael; Hillmen, Peter; Schneider, Christof; Schetelig, Johannes; Böttcher, Sebastian; Kater, Arnon P; Jiang, Yanwen; Boyer, Michelle; Popovic, Relja; Ghanim, Majd T; Moran, Michael; Sinai, Wendy J; Wang, Xifeng; Mukherjee, Nabanita; Chyla, Brenda; Wierda, William G; Seymour, John F